In Ebola Outbreak, Who Should Get Experimental Drug?
Public health authorities are wrestling with whether and how to bring an experimental medicine to the countries in Africa afflicted with the virus.
Advertise Here contact ads[@]ghheadlines.com
Related Items
Writebol
Nancy
Samaritan's Purse
Ethics and Official Misconduct
Tekmira Pharmaceuticals Corporation|TKM|TORONTO
Brantly
Kent
Epidemics
Liberia
Centers for Disease Control and Prevention
Pfizer Inc|PFE|NYSE
Drugs (Pharmaceuticals)
New York University Langone Medical Center
National Institute of Allergy and Infectious Diseases
Ebola Virus
Humanitarian Aid
Mapp Biopharmaceutical Inc
Nigeria
Fauci
Anthony S
Facebook
Twitter
Pinterest
Instagram
Google+
YouTube
LinkedIn
RSS